Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients

[1] Olatunji BO(2012)Development and initial validation of the medical fear survey-short version Assessment 19 318-336

[2] Ebesutani C(2016)Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66 271-289

[3] Sawchuk CN(1982)Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phys 8 1-11

[4] Miller KD(2001)Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725-730

[5] Siegel RL(2009)Survival after radiotherapy in gastric cancer: systematic review and meta-analysis Radiother Oncol 92 176-183

[6] Lin CC(2005)An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach Int J Radiat Oncol Biol Phys 63 1279-1285

[7] Gunderson LL(2003)Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation Int J Radiat Oncol Biol Phys 56 145-157

[8] Sosin H(2010)Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation Health Technol Assess 14 1-108

[9] Macdonald JS(2009)Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer Int J Radiat Oncol Biol Phys 74 562-566

[10] Smalley SR(2006)Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques Br J Radiol 79 497-503

[1] Olatunji BO(2012)Development and initial validation of the medical fear survey-short version Assessment 19 318-336

[2] Ebesutani C(2016)Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66 271-289

[3] Sawchuk CN(1982)Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phys 8 1-11

[4] Miller KD(2001)Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725-730

[5] Siegel RL(2009)Survival after radiotherapy in gastric cancer: systematic review and meta-analysis Radiother Oncol 92 176-183

[6] Lin CC(2005)An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach Int J Radiat Oncol Biol Phys 63 1279-1285

[7] Gunderson LL(2003)Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation Int J Radiat Oncol Biol Phys 56 145-157

[8] Sosin H(2010)Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation Health Technol Assess 14 1-108

[9] Macdonald JS(2009)Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer Int J Radiat Oncol Biol Phys 74 562-566

[10] Smalley SR(2006)Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques Br J Radiol 79 497-503